https://investors.hemostemix.com/
Hemostemix Investor Information | Clinical-Stage Biotech
Investor information for Hemostemix Inc., a clinical-stage regenerative medicine company advancing ACP-01 for vascular and ischemic disease.
investor informationclinicalstagebiotech
https://hemostemix.com/
Hemostemix
Investigational autologous cell therapy studied for peripheral arterial disease, chronic limb threatening ischemia and vascular dementia.
https://stockhouse.com/companies/quote?symbol=v.hem
Hemostemix Inc (TSXV:HEM) Stock Price Today, News, Quote & History | Stockhouse
Get today's stock prices, news and investor discussion about Hemostemix Inc (TSXV:HEM). Research HEM stock prices, stock quotes, stock trends and price history.
stock pricetoday newsquote historyinctsxv
https://www.newsfilecorp.com/release/265944/Hemostemix-Announces-TSXV-Approval-of-Debt-Settlement-at-0.20-per-Share
Hemostemix Announces TSXV Approval of Debt Settlement at $0.20 per Share
Calgary, Alberta--(Newsfile Corp. - September 10, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) ("Company"), the leading autologous...
debt settlement